Biocon gets approval from DCGI for its device CytoSorb that can treat Covid-19 Patients
Biocon’s subsidiary company Biocon Biologics got approval from the Drugs Controller General of India (DCGI) for its new device CytoSorb invented to treat critical Covid-19 Patients. CytoSorb functions as a…